Investigational Site Number : 7240010

Esplugues de Llobregat, Barcelona [Barcelona] 08950

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Running, not enrolling